Key result
Aspirin enhances antimetastatic immunity by reducing platelet activation and reversing thromboxane A2-driven T-cell suppression.
Key points are not available for this paper at this time.
Hypothesis-generating for aspirin in metastasis prevention; leaves open clinical translation and requires prospective trials.
A new study shows that aspirin enhances antimetastatic immunity by decreasing platelet activation, thereby releasing T cells from suppression by thromboxane A2.
No takes yet. Share an insight, caveat, or question.
Langley et al. (2025) studied this question. Aspirin enhances antimetastatic immunity by decreasing platelet activation and releasing T cells from suppression by thromboxane A2.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: